Oxford Immunotec Global (NASDAQ: OXFD) is one of 25 public companies in the “Diagnostic substances” industry, but how does it contrast to its rivals? We will compare Oxford Immunotec Global to similar businesses based on the strength of its dividends, institutional ownership, analyst recommendations, risk, profitability, earnings and valuation. Institutional & Insider Ownership 93.3% of […]
